Search Website Search Directory

UVM Cancer Center Logo

COLLEGE OF
MEDICINE
  • Home
  • About Us
    • Overview
    • Administration
    • Member Directory
    • Employment Opportunities
    • Events
    • Contact
  • For Members
    • Cancer Center Membership
    • Shared Resources
    • Clinical Trials Services
    • Extramural Funding
    • Intramural Funding
    • Transdisciplinary Teams (TDTs)
    • Protocol Review
      • Protocol Review
      • Submission Requirements
      • Procedures
      • Relationship to IRB
      • UVM Commons Tool
      • Protocol Review and Monitoring Committee Meetings
  • Clinical Care
    • Patients and Caregivers
    • Clinical Trials
      • Clinical Trials Office
      • Find A Cancer Trial
      • FAQs
      • Chemotherapy-Induced Peripheral Neuropathy Clinical Trial
  • Research
    • Research Programs
  • Community Outreach
    • Community Advisory Board
    • Public Health
    • Women's Health and Cancer Conference
  • Make a Gift
    • Give to the UVM Cancer Center
    • Ways to Give

  • UVM Cancer Center Investigators Publish the Breast Pre-Cancer Atlas
    January 18, 2022
    UVM Cancer Center researchers contributed to the establishment of a breast pre-cancer atlas, which establishes the molecular and cellular properties of early-stage breast cancer and is the result of a six-year, National Cancer Institute-funded, collaborative initiative.
  • Maija Reblin, Ph.D. appointed co-leader for the UVM Cancer Center’s Cancer Control and Population Health Sciences program
    January 26, 2022
  • Summer Student Research Program Trains Next Generation of Cancer Scientists
    January 26, 2022
    The UVM Cancer Center Summer Student Fellowships in Cancer Research provide $3,000 stipends to graduate and medical students for cancer-related research projects, overseen by senior faculty members affiliated with the center.
  • Now Enrolling: Clinical Trial Tests Effectiveness of Online Strength Training in Slowing Muscle Wasting in Lung Cancer Patients
    January 18, 2022
  • Adrianzen Herrera Invested as Early Career Green & Gold Professor of Medicine
    January 13, 2022
    In a ceremony held January 12, 2021, an outstanding early career physician-scientist in the University of Vermont’s Larner College of Medicine, Diego Adrianzen Herrera, M.D., was invested as the inaugural holder of the Early Career Green and Gold Professor of Medicine.
  • UVM Cancer Center Announces 2021 Pilot Project Grantees
    January 12, 2022
  • UVM Researchers Help Identify Impact of COVID-caused Delays in Breast Cancer Screening
    November 23, 2021
    New research from U.S. Breast Cancer Surveillance Consortium (BCSC) members, including several University of Vermont researchers, found that from March to September 2020, breast biopsies and detected cancers at U.S. BCSC facilities dropped sharply, compared with the same span a year earlier.
  • UVM Invests Holcombe as Inaugural J. Walter Juckett Chair in Cancer Research
    November 3, 2021
    With $3 million in support from a longtime major supporter of the University of Vermont Cancer Center, Randall F. Holcombe, M.D., M.B.A., was invested as the inaugural J. Walter Juckett Chair in Cancer Research in the Larner College of Medicine on November 3.
  • UVM Cancer Center Research Leads to First-of-Its-Kind Clinical Trial of Mesothelioma Treatment
    October 26, 2021
    Linked to occupational asbestos exposure, malignant mesothelioma (MM) is an aggressive cancer arising primarily from the outer lining of the lungs with a dismal five-year survival rate of only five to 10 percent. Since 2004, only two therapies have been approved for the treatment of MM, which affects about 3,000 people a year in the United States. Now a promising new therapy for mesothelioma and metastatic cancer, arising from laboratory investigations at the University of Vermont, is about to enter a Phase I clinical trial.
  • Strotmeyer and Lemon Recognized with 2021 UVM Our Common Ground Awards
    October 18, 2021
    Two members of the Larner College of Medicine community--Nick Lemon, information systems technical support staff member, and Katherine Strotmeyer, communications and community outreach director for the University of Vermont Cancer Center--were among the UVM stafff members who received a 2021 Our Common Ground award.
  • 24th Annual Women's Health & Cancer Conference Takes Place Virtually Oct. 1
    September 28, 2021
    The University of Vermont Cancer Center hosted the 24th annual Women’s Health and Cancer Conference on October 1 from 7:30 a.m. to 2:30 p.m. The virtual event, which was free and open to the public, was sponsored by the Victoria Buffum Fund with an aim to empower and support individuals and communities with knowledge about cancer prevention, detection, treatment, and survivorship.
  • Kolb Receives NCI Grant to Develop Treatment for Chemo-Induced Nerve Damage
    September 21, 2021
    The National Cancer Institute (NCI) has awarded Noah Kolb, M.D., associate professor of neurological sciences at the University of Vermont's Larner College Medicine, and a team of researchers a $7 million grant to a develop a new intervention for chemo-induced neuropathy, one that can be as easily implemented in rural areas as large urban centers.
  • Colchester's Vernal Biosciences Manufactures the mRNA That’s Revolutionizing Medicine
    August 25, 2021
    Read full story from Seven Days
  • FDA approval of 3rd doses of COVID-19 Vaccines
    August 31, 2021
    The FDA has revised the Emergency Use Authorizations (EUA) for both Pfizer and Moderna to authorize the use of a 3rd dose of COVID vaccine in the setting of immune compromised patients
  • Holcombe Quoted in Seven Days Article on Local mRNA Manufacturer
    August 25, 2021
    (AUGUST 25, 2021) Randall Holcombe, M.D., M.B.A., director of the UVM Cancer Center and Juckett Professor of Cancer Research, commented on the role of mRNA in cancer treatment research.
  • Radiation oncology 2.0
    August 21, 2021
    Read full story from The Lancet
  • 'They Saved My Life:' Cancer Center Clinical Trials Offer Hope to Vermont Patients
    June 23, 2021
    Read full story from Seven Days
  • UVM Students Contribute to Groundbreaking Cancer Research
    June 9, 2021
    Read full story from Seven Days
  • From Making Memes to Banning Menthol: UVM Cancer Center Researchers Target Tobacco Use
    May 12, 2021
    Read full story from Seven Days
  • Cancer Center Clinical Trial Targets Lung Tumors
    May 26, 2021
    Read full story from Seven Days
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
News Sources
  • University of Vermont Medical Center
  • Larner College of Medicine News
Tweets by UVM Cancer Center
Accessibility | Privacy/Terms of Use
Copyright 2023 | Burlington, VT